NYKODE TOLERANCE NORWAY AS
934454618ActivePioneering immunotherapy platform unlocking future medicine for serious diseases.
Oversigt
- Ukendt
- Medarbejdere
- Ukendt
- Omsætning
- 2024
- Grundlagt
Nøglebeslutningstagere
Michael Engsig
Chief Executive Officer
Agnete B. Fredriksen
Chief Scientific Officer & Business Development
Harald Gurvin
Chief Financial Officer
Louise Stubbe
Chief Legal Officer
Beskrivelse
Nykode Therapeutics ASA is a biotechnology company dedicated to advancing human health through innovative medical science. The core of their operation is the proprietary Vaccibody molecule, which forms an unrivalled modular technology platform. This platform is designed to induce fast, strong, and l...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Ukendt
Beslutningstagere
4 kontakter i FunnelfeedrMichael Engsig
Chief Executive Officer
Agnete B. Fredriksen
Chief Scientific Officer & Business Development
Harald Gurvin
Chief Financial Officer
Louise Stubbe
Chief Legal Officer
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrINCYTE BIOSCIENCES NORWAY AS
Global biopharmaceutical company developing innovative medicines for patients.
CELLMOVER AS
6 medarbejderePre-clinical immunotherapy company optimizing immune cell targeting for cancer.
ROCHE DIAGNOSTICS NORGE AS
100 medarbejdereGlobal leader in pharmaceuticals and diagnostics driving personalized medicine.
ROCHE NORGE AS
46 medarbejdereGlobal leader pioneering personalized medicine through pharmaceuticals and diagnostics.
Oncotech Nordic AB
0 medarbejdereDeveloping AI diagnostics and immunotherapy to conquer global cancer.
Udforsk mere
Spørgsmål om NYKODE TOLERANCE NORWAY AS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo